Tag: entrance
-
Omega-3 fatty acids linked to lower risk of heart disease
By Lisa Rapaport (Reuters Health) – Omega-3 fatty acids in fish and dietary supplements are associated with lower odds of heart disease even in people already at elevated risk because of excessive levels of fats or bad cholesterol in their blood, a research review suggests. The American Heart Association recommends eating at least two servings…
-
Rough start for U.S. Republicans on first day of Trump-era Congress
By Richard Cowan and Susan Cornwell WASHINGTON (Reuters) – The Republican-led U.S. Congress had a rough start to its first session of the Donald Trump era on Tuesday when a public outcry that included a dressing-down from the president-elect prompted the House of Representatives to backtrack on its plans to defang an ethics watchdog. It…
-
Rough start for U.S. Republicans on first day of Trump-era Congress
By Richard Cowan and Susan Cornwell WASHINGTON (Reuters) – The Republican-led U.S. Congress had a rough start to its first session of the Donald Trump era on Tuesday when a public outcry that included a dressing-down from the president-elect prompted the House of Representatives to backtrack on its plans to defang an ethics watchdog. It…
-
Children aged 7 to 17 killed in Texas home by toxic chemical gas
Four children aged 7 to 17 died after a toxic gas leak from a pest control product at their home in Amarillo, Texas, fire officials said on Tuesday. Six others survived the incident, with Martha Balderas, the mother of the children, in critical condition at a hospital in the nearby Texas Panhandle city of Lubbock,…
-
Why you shouldn’t treat earwax without seeing a doctor
“Patients may try to blindly instrument their ears with cotton ear buds, bobby pins, or other tools,” said Dr. Seth Schwartz, chair of a committee that drafted new guidelines for diagnosing and treating earwax for the American Academy of Otolaryngology – Head and Neck Surgery. “Scratching of the ear canal skin can lead to pain…
-
No early win for Sanofi, Regeneron cholesterol drug in study
(Reuters) – Sanofi and Regeneron Pharmaceuticals said on Thursday they would continue a large clinical outcomes study with their injectable cholesterol-lowering drug Praluent. There had been an option for the trial to be stopped early if it showed overwhelming efficacy at the interim stage but an independent data monitoring committee recommended it should continue. The…
-
Drugmakers under fire for possible U.S. price fixing
The request by U.S. Senator Bernie Sanders and Representative Elijah Cummings follows a similar letter they sent last fall calling for an investigation into 14 drug companies over price increases of generic drugs. U.S. prosecutors could file the first charges by the end of the year in their subsequent criminal investigation of generic drugmakers over…